An alternative, effective pretransplant transfusion method

Small-aliquot, repeated transfusions from the same third-party, HLA-defined blood donor

L. Burrows, H. Schanzer, C. Miller, Robert E. Feingold, M. Fotino

Research output: Contribution to journalArticle

Abstract

We have used an unusual if not unique method of transfusion for the prospective, previously untransfused recipients of living related (LR) or cadaveric (CAD) first renal grafts. A single unit of third-party, HLA-defined blood is administered in three aliquots to these patients before grafting. The technique is based on the hypothesis that it is the repeated administration of mismatched HLA-DR in a 'booster' fashion that is responsible for maximizing graft survival. This unique method of pretransplant transfusion is safe, effective, and conserved blood. It compares favorably with other transfusion protocols and appears to augment the results in Cs-treated patients. It will not sensitize recipients to their related kidney donors and eliminates the need to treat these recipients with immunosuppressive agents during the transfusion period. It has the potential of minimizing the sensitization profile of prospective CAD kidney recipients to only a few selected mismatched major histocompatibility antigens.

Original languageEnglish (US)
Pages (from-to)289-291
Number of pages3
JournalTransplantation Proceedings
Volume20
Issue number1 SUPPL. 1
StatePublished - 1988
Externally publishedYes

Fingerprint

Blood Donors
Kidney
Histocompatibility Antigens
HLA-DR Antigens
Graft Survival
Immunosuppressive Agents
Tissue Donors
Transplants

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

An alternative, effective pretransplant transfusion method : Small-aliquot, repeated transfusions from the same third-party, HLA-defined blood donor. / Burrows, L.; Schanzer, H.; Miller, C.; Feingold, Robert E.; Fotino, M.

In: Transplantation Proceedings, Vol. 20, No. 1 SUPPL. 1, 1988, p. 289-291.

Research output: Contribution to journalArticle

@article{bca62493cd0f4d2ca8eaf2c54451ad0a,
title = "An alternative, effective pretransplant transfusion method: Small-aliquot, repeated transfusions from the same third-party, HLA-defined blood donor",
abstract = "We have used an unusual if not unique method of transfusion for the prospective, previously untransfused recipients of living related (LR) or cadaveric (CAD) first renal grafts. A single unit of third-party, HLA-defined blood is administered in three aliquots to these patients before grafting. The technique is based on the hypothesis that it is the repeated administration of mismatched HLA-DR in a 'booster' fashion that is responsible for maximizing graft survival. This unique method of pretransplant transfusion is safe, effective, and conserved blood. It compares favorably with other transfusion protocols and appears to augment the results in Cs-treated patients. It will not sensitize recipients to their related kidney donors and eliminates the need to treat these recipients with immunosuppressive agents during the transfusion period. It has the potential of minimizing the sensitization profile of prospective CAD kidney recipients to only a few selected mismatched major histocompatibility antigens.",
author = "L. Burrows and H. Schanzer and C. Miller and Feingold, {Robert E.} and M. Fotino",
year = "1988",
language = "English (US)",
volume = "20",
pages = "289--291",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "1 SUPPL. 1",

}

TY - JOUR

T1 - An alternative, effective pretransplant transfusion method

T2 - Small-aliquot, repeated transfusions from the same third-party, HLA-defined blood donor

AU - Burrows, L.

AU - Schanzer, H.

AU - Miller, C.

AU - Feingold, Robert E.

AU - Fotino, M.

PY - 1988

Y1 - 1988

N2 - We have used an unusual if not unique method of transfusion for the prospective, previously untransfused recipients of living related (LR) or cadaveric (CAD) first renal grafts. A single unit of third-party, HLA-defined blood is administered in three aliquots to these patients before grafting. The technique is based on the hypothesis that it is the repeated administration of mismatched HLA-DR in a 'booster' fashion that is responsible for maximizing graft survival. This unique method of pretransplant transfusion is safe, effective, and conserved blood. It compares favorably with other transfusion protocols and appears to augment the results in Cs-treated patients. It will not sensitize recipients to their related kidney donors and eliminates the need to treat these recipients with immunosuppressive agents during the transfusion period. It has the potential of minimizing the sensitization profile of prospective CAD kidney recipients to only a few selected mismatched major histocompatibility antigens.

AB - We have used an unusual if not unique method of transfusion for the prospective, previously untransfused recipients of living related (LR) or cadaveric (CAD) first renal grafts. A single unit of third-party, HLA-defined blood is administered in three aliquots to these patients before grafting. The technique is based on the hypothesis that it is the repeated administration of mismatched HLA-DR in a 'booster' fashion that is responsible for maximizing graft survival. This unique method of pretransplant transfusion is safe, effective, and conserved blood. It compares favorably with other transfusion protocols and appears to augment the results in Cs-treated patients. It will not sensitize recipients to their related kidney donors and eliminates the need to treat these recipients with immunosuppressive agents during the transfusion period. It has the potential of minimizing the sensitization profile of prospective CAD kidney recipients to only a few selected mismatched major histocompatibility antigens.

UR - http://www.scopus.com/inward/record.url?scp=0023945266&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023945266&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 289

EP - 291

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 1 SUPPL. 1

ER -